JANX
Work Here?
Overview
About JANX
Simplify's Rating
Why JANX is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation
Industries
Consulting
Industrial & Manufacturing
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Parma, Ohio
Founded
1981
Your Connections
People at JANX who can refer or advise you
Simplify's Take
What believers are saying
- BMS collaboration provides $35M upfront plus development, regulatory, and commercial milestones.
- JANX008 Phase 1 enrollment and JANX011 first-in-human dosing advance clinical validation.
- Tumor-activated approach reduces off-target toxicity versus conventional T cell therapies.
What critics are saying
- BMS termination or deprioritization eliminates material funding and validation signal.
- JANX011 Phase 1 adverse events or efficacy failure damages platform credibility.
- Clinical-stage biotech requires continuous capital raises; market downturns force dilution.
What makes JANX unique
- TRACTr platform selectively activates T cells against tumor antigens with precision engineering.
- Dual-pipeline approach targets both cancer and autoimmune diseases with same core technology.
- Bristol Myers Squibb validation and $35M milestone payment demonstrate platform credibility.
Help us improve and share your feedback! Did you find this helpful?
Benefits
Health Insurance
There are no jobs for JANX right now.
Find jobs on Simplify and start your career today
We update JANX's jobs every few hours, so check again soon! Browse all jobs →
About JANX
Simplify's Rating
Why JANX is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation
Industries
Consulting
Industrial & Manufacturing
Company Size
51-200
Company Stage
N/A
Total Funding
N/A
Headquarters
Parma, Ohio
Founded
1981
There are no jobs for JANX right now.
Find jobs on Simplify and start your career today
We update JANX's jobs every few hours, so check again soon! Browse all jobs →